MDPHP is thought to act largely as a potent norepinephrine-dopamine reuptake inhibitor (NDRI). Minimized re-uptake of norepinephrine and dopamine ends in increased concentrations of the two catecholamine neurotransmitters within the synaptic cleft, or hole between neurons. The result of this inhibition is really an enhanced and extended concentration and ensuing https://monkeydrug94826.bloggerswise.com/38099459/the-fact-about-monkey-drug-that-no-one-is-suggesting